International Congress on ATTR Amyloidosis

Saturday, October 16, 2021
Saturday, October 23, 2021

The 1st Annual International Congress on ATTR Amyloidosis (ICAA) will explore the disease state, diagnosis, and the latest advancements and treatments in the management of amyloidosis. This conference is an opportunity to gain knowledge on new developments in this complex disease. Leading experts will present clinically relevant information that you will find immediately useful in the care of your patients.

swoosh
swoosh

LETTER FROM THE CO-CHAIRS

Dear Medical and Scientific Colleagues:

It is our pleasure and privilege to welcome you to the 1st Annual International Congress on ATTR Amyloidosis (ICAA) Conference. From the moment you enter the Virtual Conference Center, you’ll spend two days engaging in a lively, interactive conference experience. You’ll be able to participate in livestreamed sessions on a wide range of topics in ATTR Amyloidosis, discuss the practical application of emerging insights in routine clinical care, and participate in Q&A after each session to get your questions answered. Each session also comes with downloadable slides for your reference.

As in any live conference venue, you will find robust opportunities to interact with your colleagues beyond the educational sessions. There is much to explore! We encourage you to take full advantage of these conference features including:

  • Peer-to-peer learning in the Virtual Poster Hall
  • Networking with other specialists and practitioners in the Lounge
  • An interactive Poster Hall for continued learning

Should you be unable to attend, each recorded session will be available for on-demand access until October 2022.

Once again, welcome! We hope you will enjoy this one-of-a-kind virtual conference, benefit from the learning opportunities, and gather many clinical pearls to “bring home” to your practice!

Sincerely,

 

Mazen Hanna, MD
Co-Chair

Co-Director, Amyloidosis Center
Section of Heart Failure & Transplantation
Cleveland Clinic Foundation
Cleveland, OH

Brett Sperry, MD
Co-Chair

Assistant Professor of Medicine
University of Missouri-Kansas City
Co-Director of Cardiac Amyloidosis Program
St. Luke’s Health System
Kansas City, MO

CO-CHAIRS


 


 

company name

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.  

company name

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.